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ISSUES IN IMAGING
MR imaging of bone marrow in patients with musculoskeletal tumors
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Abstract
Knowledge of the appearances of normal bone marrow, metastases involving marrow, and therapy-related marrow changes
shown by MR imaging is necessary in order to avoid misdiagnosis. This article reviews MR imaging techniques and the
® ndings that allow distinction of normal yellow (fatty) marrow and red marrow from tumor in marrow, as well as the
identi® cation of marrow changes resulting from radiation therapy or treatment with marrow-stimulating drugs in patients
with musculoskeletal tumors.
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A quantity of bone marrow is visible on virtually
every magnetic resonance (MR) imaging examina-
tion performed. Depending on factors such as patient
age, the relative degree of hematopoietic activity
present, and the body part being examined, various
amounts of red marrow, yellow (fatty) marrow, or
both will be seen on the images.
1± 4The MR imaging
appearance of marrow is greatly affected by the
speci® c MR pulse sequence employed, as well as by
use of special options such as fat-suppression pulses.
This article will review the common MR imaging
techniques used for evaluating bone marrow and the
MR imaging appearance of normal and abnormal
marrow; of necessity, this is not a comprehensive
review of MR imaging of the entire spectrum of
marrow disorders.
MR imaging techniques for evaluating marrow
OnT1-weighted conventional spin-echo images, fatty
marrow is readily identi® able by its high signal
intensity, similar to that of subcutaneous fat, whereas
red marrow shows intermediate to low signal intensity
(Fig. 1a).
1 Regions of red marrow can be homo-
geneous or have a patchy distribution, and often show
a feathery interface with adjacent fatty marrowÐ an
important clue to their correct differentiation from
tumor deposits. A small island of red marrow often
can be characterized as such when one or more foci
of central (bright) fat are visible within it on
T1-weighted imagesÐ the so-called `bull’s-eye’ sign,
which has a reported sensitivity of 95% and a speci® -
city of 99.5% for normal hematopoietic marrow.
5 In
contrast, tumor deposits in marrow typically appear
relatively homogeneous, and show low signal and no
central high signal on T1-weighted images
(Fig. 2).
1,5,6
On T2-weighted conventional spin-echo images,
fatty marrow has an intermediate signal intensity,
similar to or slightly higher than that of red marrow
(Fig. 1b), whereas tumor deposits manifest a
moderately bright signal.
1,6Tumor deposits in marrow
often show a `halo’ sign on T2-weighted images,
consisting of a rim of high signal surrounding a region
of lower signal (Fig. 3); this sign has a reported
sensitivity of 75% and a speci® city of 99.5%.
5 Of
note is the fact that fatty marrow (like fat in general)
has moderately high signal on the newer `fast’ (`turbo’)
spin-echoT2-weighted sequences (Fig. 1c),
7 and thus
can obscure adjacent tumor deposits or other patho-
logic processes. It is important to use frequency-
selective fat-saturation (i.e., fat-suppression) pulses
when evaluating marrow on T2-weighted fast spin-
echo images (Figs 1d and 3) to improve the signal
difference between tumor and normal marrow.
7,8
Another fat-suppression technique is the short-tau
inversion recovery (STIR) sequence, which yields very
high signal from abnormal marrow contrasted against
very low signal from fat.
8,9
Chemical shift images produced with in-phase and
opposed-phase gradient echo pulse sequences are
easily obtained on modern MR imaging units by
appropriate selection of echo times (TE); for example,
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opposed-phase, and those obtained withTE=4.2 msec
are in-phase. Because fatty marrow and red marrow
both contain some amounts of both fat and water,
the signal from either type of normal marrow will
decrease to some extent on opposed-phase images
(Fig. 4); in contrast, no fat is present within most
primary or metastatic tumors within marrow, so tumor
in marrow will not show such a signal loss.
10
Administration of a gadolinium-based intravenous
contrast material will cause most tumors in marrow
to enhance, resulting in a higher signal on
T1-weighted images (Fig. 5). Again, a
fat-suppression technique should be used to increase
the conspicuity of enhancing tumor against
surrounding fatty marrow.
Post-treatment changes
Within several weeks of radiation therapy, irradiated
bone marrow shows increased signal on T1-weighted
images, similar to that of subcutaneous fat, due to
conversion to fatty marrow.
11,12The interface between
irradiated and nonirradiated marrow is typically
straight and abrupt.
In patients in whom the bone marrow has been
stimulated by anemia, regions of fatty marrow will
reconvert to active red marrow, typically progressing
from the central skeleton to more peripheral portions
of the skeleton as the severity of anemia increases.
1
Reconversion to red marrow can be difficult to
con® dently distinguish from tumor involvement by
MR imaging in some cases;
13 correlation with the
expected pattern of metastasis for the speci® c tumor
in a given patient can often help make this distinc-
tion.
Granulocyte-colony stimulating factor (G-CSF) is
increasingly being administered to promote hemat-
opoietic activity during chemotherapy in an attempt
(a) (b)
(c) (d)
Fig. 1. Normal red marrow and fatty marrow. T1-weighted spin-echo axial image (a) of normal marrow in femoral shaft shows
subcortical distribution of red marrow (arrow), which has lower (grayer) signal than bright signal from more centrally located fatty
marrow (asterisk). Similar signal intensity relationships are shown in marrow on T2-weighted conventional spin-echo (b) and
T2-weighted fast spin-echo (c) axial images.T2-weighted fat-suppressed fast spin-echo axial image (d) at same anatomic level shows
reversal of signal pattern compared to (a± c); relatively higher signal from subcortical red marrow could be confused with tumor
(see Fig. 3).
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therapy-induced neutropenia. This hematopoietic
growth factor (and others like it) often causes multiple
regions of red marrow to develop in previously fatty
marrow, manifesting as regions of high signal on
T2-weighted images (Fig. 6).
13,14 Knowledge of this
common effect of G-CSF, combined with information
about the individual patient’s clinical status, usually
makes it clear that the interval development of multiple
new marrow metastases is unlikely in that patient.
(a)
(b)
Fig. 2. Metastatic tumor in marrow:T1-weighted imaging.T1-weighted spin-echo axial images of proximal femoral shafts (a) and left
iliac wing (b) show relatively low signal from metastases (arrows) in marrow from liposarcoma (previously resected from soft tissues
of left hip).
MRI of bone marrow 39Fig. 3. Metastatic tumor in marrow: halo sign. T2-weighted
fat-suppressed fast spin-echo coronal image of femoral shaft
containing marrow metastasis from lung carcinoma shows `halo’
sign, consisting of a rim of high signal (arrow) surrounding the




Fig. 4. Metastatic tumor in marrow: chemical shift imaging.
In-phase gradient echo axial image (a) of right lower hemipelvis
shows deposit of metastatic renal cell carcinoma (black arrows)
in marrow of right pubic bone.The tumor deposit has relatively
low signal; fatty marrow (white arrow) has bright signal; and
red marrow has intermediate signal (asterisk). On the
corresponding opposed-phase image (b), the lesion (T) is much
more conspicuous, as red marrow (asterisk) has become much
darker due to cancellation of virtually all bright signal from the fat
present within the red marrow.Areas of very fatty marrow (arrow)
did not become as dark, because only a minimal amount of water
was present to cancel only some of the bright signal from fat.
(a)
(b)
Fig. 5. Metastatic tumor in marrow: gadolinium-enhanced
imaging. Pre-injection fat-suppressed T1-weighted axial image
(a) shows metastasis of renal carcinoma (arrow) in marrow of
right pubic bone (same patient as in Fig. 4), with minimally
higher signal than surrounding tissues. Following intravenous
administration of gadolinium-based contrast material (b), the
tumor deposit (T) markedly enhances, increasing its conspi-
cuity. Note similar enhancement of prostate (p), minimal
enhancement of edema in marrow medial to lesion (asterisk),
and lack of enhancement in bone marrow elsewhere.
Fig. 6. Growth factor effect. T2-weighted fat-suppressed fast
spin-echo axial image of distal tibia in an adolescent patient
who had recently completed preoperative chemotherapy, including
G-CSF, for osteogenic sarcoma of femur. Multiple small foci of
high signal intensity (arrows),representing islands of red marrow,
developed in areas of previously fatty marrow as a result of
therapy; these foci should not be mistaken for multiple new
metastases.
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